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M Pasic, and L v Segesser 
Objective: The aim was to assess the effect of nisoldipine on left ventricular systolic and diastolic function 
during prolonged myocardial ischaemia. Methods: The left circumflex coronary artery was ligated for 2 h and 
reperfused for 4 h in 12 calves. The animals were randomised to a control group (n=6) or to treatment with 
1.25 mg.h-' intravenous nisoldipine (n=6) during 2 h of ischaemia. Circulatory support by a ventricular assist 
device was performed throughout the experiment except for the time of haemodynamic measurements. Regional 
wall thickening of a normal and an ischaemic left ventricular region was determined using pairs of ultrasonic 
crystals. Left ventricular pressure was measured by micromanometry. Left ventricular wall thickness and regional 
wall stiffness at a common preload of 10 mm Hg were calculated using an elastic model with shifting asymptote. 
Results: Ten animals survived after 6 h. No difference was observed in systolic function between controls and 
nisoldipine treated animals. Systolic thickening of the ischaemic wall remained depressed 4 h after reperfusion 
and showed some recovery after dopamine infusion. Ischaemic wall stiffness at a common preload was lower 
after nisoldipine during ischaemia and reperfusion than in controls. Control wall stiffness remained unchanged 
during the whole experiment with and without nisoldipine. Diastolic thinning of the ischaemic wall was 
prevented by nisoldipine during ischaemia and after reperfusion. Conclusions: Prolonged myocardial ischaemia 
is associated with increased myocardial stiffness of the ischaemic wall. Mechanical unloading can help to bridge 
the acute phase but cannot prevent postischaemic diastolic dysfunction of the ischaemic wall. Nisoldipine has 
a beneficial effect on regional diastolic function during ischaemia and reperfusion by decreasing regional wall 
stiffness and preventing diastolic thinning of the ischaemic wall. 
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rolonged myocardial ischaemia is associated with 
regional myocardial dysfunction which can persist for P hours and days and may lead to irreversible 
myocardial damage. Diastolic dysfunction has been reported 
in the experimental animal during acute ischaemia" as well 
as during postreperfusion myocardial stunning.' ' Admin- 
istration of calcium antagonists beneficially influences 
diastolic dysfunction after short term ischaemia.h However, 
long term ischaemia has not yet been studied with regard to 
diastolic dysfunction and its reversibility with calcium 
antagonists. Long term ischaemia is often associated with 
variable myocardial damage and may be accompanied by 
severe arrhythmias and low output failure.'-" It has been 
shown previously that systolic function can be preserved 
during long term myocardial ischaemia by extracorporeal 
circulatory However, the effect of prolonged 
ischaemia on regional diastolic dysfunction was not 
evaluated. Thus the purpose of the present study was ( 1 )  to 
assess the effect of long term myocardial ischaemia on 
regional diastolic dysfunction and ( 2 )  to determine the 
influence of nisoldipine, a new calcium antagonist of the 
dihydropyridine group, on regional passive elastic properties 
of the ischaemic and postischaemic myocardium. 
Methods 
Twelve calves with a mean body weight of 72 kg underwent left 
thoracotomy under general anaesthesia with 0.25 n1g.kg-I Polamivet 
(morphine derivative) and 0.04 n1g.kg-l Combelen (phenothiazine 
derivative) in  combination with 10 mg.kg thiopentone. Animals were 
treated in accordance with the principles of laboratory animal care at 
our hospital. The study protocol was approved by the local animal 
ethics committee. The preparation of the animals and the 
instrumentation used in this study have been described in detail 
elsewhere." BrieHy. the left atrium and the descending aorta as well as 
the right atrium and the pulmonary artery were cannulated surgically 
and connected to a ventricular t device (Abiomed model 5000. 
Danvers, MA. USA).  This device includes a driving unit and a 
disposable paracorporeal blood system which is connected to the right 
atrium and the pulmonary artery or to the left atrium and the aorta. The 
assist device contains two chambers and two trileaflet valves for How 
direction." '' Left ventricular pressure was measured with an 8F Millar 
pigtail micromanometer catheter which was inserted through the left 
atrial appendage into the left ventricle. Aortic pressure was determined 
with a Huid filled 8F pigtail catheter which was positioned in the 
ascending aorta. Pairs of ultrasonic crystals were implanted in the 
region perfused by the left anterior descending coronary artery 
(=control wall) and in the region perfused by the left circurnHex 
coronary artery (=ischaemic wall) for measuring left ventricular wall 
thickness.' Coronary blood How velocity in the proximal left anterior 
descending and the left circumHex coronary arteries was measured by 
Doppler sonomicrometry (Triton Technology. San Diego. CA, USA). 
using two Doppler How probes with an internal diameter of 3 mm. 
Myocardial ischaemia was induced by ligation of the left circumfex 
coronary artery. The Doppler probe was placed approximately 2 cm 
distal to the ligature. 
E.rl,rrirnentcil protocol (fig I )  
After completion of the instrumentation, an interval of 10 to 15 min was 
allowed for stabilisation of the haemodynanlic variables. Then the 
control run was performed. after which the circumflex artery was 
ligated for a total duration of 2 h. During the 2 h of ischaemia a 
continuous infusion of intravenous nisoldipine ( 1.25 1ng.h-l) was given 
in six randomly selected animals (nisoldipine group). whereas the other 
six animals served as controls (control group). Two hours after ligation 
of the left circumHex coronary artery. the vessel was released. 
nisoldipine infusion stopped. and the heart reperfused for the following 
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Figure I Experimental protocol: haemodynamic measurements 
were performed at rest (B), after 2 min ( I )  and 2 h (I2) of ischaemia, 
after 4 h of reperjkion (R4), and during dopamine infusion (Dj 
(1000 pgugmin-'). Ventricular unloading was started immediately 
after the induction of ischaemia and was continued throughout the 
experiment. Nisoldipine ( N )  was given intravenously during the 
2 h of ischaemia. 
4 h. Unloading of both ventricles was performed from the beginning 
of ischaemia to the end of the experiment (fig I) .  This procedure was 
necessary because ventricular fibrillation occurred frequently due to the 
extent and duration of the ischaemia. Thus there was no control group 
without unloading. Haemodynamic measurements were carried out at 
rest, after 2 min, 1 h, and 2 h of ischaemia as well as after 1 ,  2, and 
4 h of reperfusion (fig 2).  During the short time period in which the 
measurements were performed, the assist device was stopped. After 
turning off the device the heart was allowed to regain its normal pump 
function with stable blood pressure for 1 to 3 min [mean 113 (SD 88) 
s]. At the end of the experiment the assist device was turned off and 
the haemodynamic measurements were repeated at rest and under 
inotropic stimulation with dopamine, starting at a dose of 250 pgmin-' 
and increasing at 2 min intervals to 500 and 1000 kgmin-'. Data are 
reported at rest, after 2 min and 2 h of ischaemia, after 4 h of 
reperfusion, and during dopamine infusion with 100 pg.minF (fig 2). 
Data analysis 
Left ventricular pressure and wall thickness tracings were digitised 
manually for three cardiac cycles using an electronic digitiser interfaced 
to a computer. Data were transferred to a personal computer for further 
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analysis. Data were analysed for three cardiac cycles and plotted at 5 
ms intervals. 
Systolic function was assessed from systolic left ventricular wall 
thickening of the normal and ischaemic wall. Systolic wall thickening 
was calculated as end systolic minus end diastolic wall thickness 
divided by end diastolic wall thickness multiplied by 100. End diastole 
was defined as the time of the rapid upstroke of dP/dt and end systole 
as the time at which left ventricular pressure fell below aortic incisural 
pressure. Normalisation of left ventricular wall thickness was carried 
out according to Osakada and coworkers" by dividing wall thickness 
by its resting end diastolic thickness and multiplying by 10. 
Diastolic function was assessed from the time constant of 
isovolumetric relaxation and regional left ventricular wall stiffness. The 
time constant of relaxation (T; ms) was calculated as the negative 
reciprocal of the slope of the linear regression between pressure and 
negative dP/dt during isovolumetric relaxation." The extrapolated 
baseline pressure (Pb; mm Hg) was calculated as the pressure at 
dP/dt=O. The isovolumetric relaxation period was defined as the time 
interval beginning immediately after maximum negative dP/dt and 
ending when pressure had decreased to 5 mm Hg above left ventricular 
end diastolic pressure.IR 
Regional passive elastic properties of the left ventricular wall were 
assessed from the diastolic pressure-wall thickness relationship between 
minimum left ventricular pressure and end diastole. An elastic model 
with shifting asymptote was used to calculate regional wall stiffness: 
P=axebxh+c 
where P=left ventricular pressure (mm Hg), a=elastic constant 
(mm Hg), b=constant of regional wall stiffness (I/mm), h=normalised 
wall thickness (rnm), and c=asymptote of the exponential pressure- 
wall thickness relationship (mm Hg). The three constants, a, b and c, 
were determined by an iteration procedure designed by one of us (MJ). 
Operative regional left ventricular wall stiffness at a common preload 
of 10 mm Hg was calculated as 
dP/dh=bx( 10-c) 
where dP/dh is the instantaneous wall stiffness at 10 mm Hg 
(mm Hg.mm-').ly Left ventricular wall thickness at a common preload 
of 10 mm Hg was calculated as 
h=(ln[ IO-c]-ln[a])/b 
where In is the natural logarithm. 
Statisrics 
Statistical comparisons of haemodynamic data obtained during the 
control run, after 2 min and 2 h of ischaemia, after 4 h of reperfusion, 
and under dopamine were performed by an analysis of variance for 
repeated measurements. If the analysis was significant, the Schefft! 
procedure was applied. Comparisons of data between the control and 
nisoldipine group were camed out by the Mann-Whitney test for two 
independent groups. Values are given as means (SD). 
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Figure 2 Original tracing showing the haemodynamic variables measured at rest (B), during ligation of the left circumjex coronary artery 
(LCX), after 2 min ( I )  and 2 h (I,) of ischaemia, after 4 h of reperfusion (R4), and during dopamine infusion (D). Control (CW) and ischaemic 
(IW) wall thickness, coronary jlow velocity (CFV) of the LCX, leji ventricular pressure (LVP) and aortic pressure (AoP) were measured 
in all animals. Systolic bulging of the ischaemic wall can be seen during acute ischaemia (arrows) but 4 h after reperfusion and during 
dopamine infusion ischaemic wall thickening is back to control. 
Diastolic dysfunction afrer ischaemia 533 
Results 
Original tracings illustrating the variables measured are 
shown in figure 2. One animal of each group developed 
ventricular fibrillation during ischaemia which could not be 
terminated despite several attempts. These two animals were 
therefore excluded from further evaluation. Severe hypo- 
tension (systolic pressure 4 0  mm Hg) was observed during 
ischaemia and reperfusion in five of the 10 animals when the 
ventricular assist device was turned off. 
Standard haemodynamic variables (table I )  
Heart rate was slightly but not significantly lower in the 
animals treated with nisoldipine compared to the control 
animals. Peak systolic pressure decreased significantly 
during ischaemia and reperfusion and was back to control 
during dopamine infusion in the nisoldipine group, whereas 
the changes in the control group were not significant. End 
diastolic pressure did not change during the experiment and 
did not differ between the two groups. The time constant of 
relaxation increased in both groups during ischaemia and 
reperfusion and returned to control values during dopamine 
infusion. Nisoldipine tended to prolong relaxation, and this 
was significantly longer after 2 min of ischaemia than in the 
control group. The pressure baseline of the isovolumetric 
pressure decline at dP/dt=O was slightly but not significantly 
higher in the nisoldipine group. 
Coronary jlow velocity (jig 3)  and regional systolic function 
(table 11) 
Coronary flow velocity decreased significantly in the 
circumflex artery after ligation; however, flow was not zero. 
Coronary flow velocity in both the left anterior descending 
and the left circumflex coronary arteries was slightly 
although not significantly higher in the nisoldipine group 
(fig 3). 
0 LAD 
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Figure 3 Coronary flow velocity of the left circumflex coronary 
artery (LCX=ischaemic wall region) and of the left anterior 
descending coronary artery (LAD=control wall region) at baseline 
(B) ,  after 2 rnin ( I )  and 2 h ( I 2 )  of ischaemia, after 4 h of reperfusion 
( R J ,  and during dopamine infusion (D). Values are means, 
bars=SEM. Coronary flow velocity remained unchanged in the 
LAD but decreased significantly in the LCX region after coronary 
ligation. Flow returned to control levels during reperjiusion and 
increased significantly during dopamine infusion. Nisoldipine (niso) 
tended to increase coronary jlow velocity compared to control 
(NS).  
*p<0.05 v LCX; tp<0.05 v B. 
Left ventricular end diastolic wall thickness of the control 
wall remained unchanged in both groups during ischaemia 
and reperfusion; however, it was significantly greater in the 
nisoldipine group during dopamine infusion than in controls. 
Table I Haemodynamic variables. Values are means (SD), n=5 per group 
Heart rate (beats.min-') LVEDP (mm Hg) LVSP (mm Hg) T (ms) Pb (mm Hg) 
C N C N C N C N C N 
Baseline 116(9) 102(22) 11(6) Il(4) 90(21) 89(6) 46(7) 50(9) 4 ( 9 )  -1(7) 
lschaemia ( 2  min) 117(10) 94(23) 13(6) 15(4) 83(18) 64( 17) 47(12) 78(28)$ -7i12) 7(12) 
Ischaemia (2 h) 106( 10) 80(22)$ ll(4) 12(4) 62(13) 47(2 I )* 73(26) 88(34) -9(11) 6(7) 
Reperfusion (4 h) 101 (33) 78(28) 16(7) 13(7) 69( 19) 55( 19)* 73(42) 91(26)* -4(10) 2(15) 
Dopamine infusion l06( 12) 99(42) 15(7) 13(7) 112(22)1$ 87(30)t$ 45(10) 58(20) 4 1 2 )  -3(18) 
C=control group; N=nisoldipine group; LVEDPdeft ventricular end diastolic pressure; LSVP=left ventricular systolic pressure; T=time constant of left 
ventricular relaxation; Pb=pressure asymptote at dP/dt=O; *p<0.05 v baseline. 
tp<0.05 v ischaemia (2 h); $p<0.05 v reperfusion (4 h) (ANOVA for repeated measures); §p<0.05 v control (Mann-Whitney test for independent groups). 
Table II  Left ventricular wall thickness and wall thickening. Values are means (SD), n=5 per group 
CWed (mm) IWed (mm) %CW %IW 
C N C N C N C N 
Baseline 10.0(0.0) lO.O(O.0) 10.0(0.0) lO.O(O.0) 9(4) IO(5) 9(2) I O U )  
Ischaemia (2 h) 10.2( 1.3) I0.3(0.4) 9.1(0.9) 9.6(0.8) 4 6 ) t  5(9)t -7(3)*$ 4(4)*$  
Reperfusion (4 h) 10.0( 1 .  I )  Il.2( 1.6) 9.4(0.8) 10.2( 1.9) 5(10)t 9(12)t -2(3)* -2@) 
Dopamine infusion 9.8(0.9) I1.9( 1.7)t$ 9.4(0.9) 10.3(2.7) I l ( 1 1 )  11(8) 1 (6)$ 6(8) 
Ischaemia ( 2  min) 9.5(0.2) 9.6(0.5) 9.4(0.3) 8.7(0.7) 16(10) 20i 12)* -6(5)*$ -7(10)*$ 
~~ ~ 
CWed, lWed=end diastolic wall thickness of the control and ischaemic wall, respectively; %CW, %IW=percent wall thickening of the control and ischaemic 
wall, respectively; other abbreviations as in table I .  *p<0.05 v baseline. 
tp<0.05 v ischaemia (2 min); (ANOVA for repeated measures); $p<0.05 v equivalent %CW value; $p<0.05 v control (Mann-Whitney test for independent 
groups). 
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No difference between the control and nisoldipine groups 
was found for end diastolic wall thickness of the ischaemic 
wall. 
Systolic thickening of the control wall increased in both 
groups during 2 min of ischaemia, whereas the ischaemic 
wall showed systolic bulging with and without nisoldipine 
(table 11). During dopamine infusion systolic thickening of 
the control wall was back to control values but thickening of 
the ischaemic wall showed persisting dysfunction which was 
slightly less after nisoldipine treatment. 
Regional diastolic function 
Regional wall stiffness at a common preload of 10 mm Hg 
showed considerable differences between the control and the 
nisoldipine group (fig 4). Regional wall stiffness of the 
control wall was not altered throughout the experiment in 
either group. The ischaemic wall of the control group 
showed increased stiffness during ischaemia which did not 
return to control after reperfusion, whereas regional stiffness 
of the ischaemic wall remained unchanged during ischaemia 
and reperfusion in the nisoldipine group (fig 4). The 
reference wall thickness at a common preload of 10 mm Hg 
did not change in the control wall region. In the ischaemic 
wall region of the control group, however, reference wall 
thickness decreased during ischaemia and reperfusion and 
was significantly thinner in the control than in the nisoldipine 
group (fig 5) .  
Discussion 
Ventricular unloading by mechanical circulatory support is 
effective in protecting myocardial systolic function during 
long term myocardial ischaemia." Mechanical unloading 
has been shown not only to prevent severe left ventricular 
dysfunction but also to salvage ischaemic myocardium when 
compared to reperfusion alone." The purpose of the present 
0 I W (n = 4) 
0 CW niso (n = 5) 
I W niso (n = 4) 
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Figure 4 Regional wall stiffness (-dP/dh) at a common preload 
of 10 mm H g  of the control (CW; circles) and the ischaemic wall 
( IW;  squares) at rest (BJ,  after 2 h of ischaemia (I2),  and after 4 
h of reperfusion (RJ in the control (white symbols) and nisoldipine 
group (niso; black symbols). Values are means, bars=SEM. 
Regional sti@ess of the ischaemic wall increased during ischaemia 
in the control group, whereas it remained unchanged in the 
nisoldipine group. Regional wall stiffness of the control wall 
remained unchanged throughout the experiment. 
study was to evaluate the influence of mechanical unloading 
on diastolic dysfunction and to study the effect of nisoldipine 
on regional passive elastic properties of the ischaemic and 
postischaemic myocardium. 
Regional coronary blood flow during ischaemia 
Long term myocardial ischaemia was associated with a 
significant reduction in coronary blood flow (fig 3)  
although flow was not zero after ligation of the left 
circumflex coronary artery. This might be explained by the 
presence of collateral perfusion or by some connections 
between the ligature and the flow probe. This collateral 
perfusion is certainly small but can be enhanced during 
ventricular unloading." Thus collateral perfusion could 
explain some beneficial effect on the ischaemic 
myocardium.20 However, collateral perfusion is usually not 
enough to maintain normal left ventricular function during 
coronary ligation and hence systolic bulging occurred in all 
animals after ligation of the circumflex coronary artery (table 
11). Collateral flow was antegrade in the ligated circumflex 
artery, suggesting significant collaterals close to the coronary 
flow probe. 
Regional lej? ventricular function during ischaemia 
The ischaemic wall showed systolic bulging after occlusion 
of the circumflex artery, whereas hypercontractions occurred 
in the normal wall during the initial phase of ischaemia. This 
contrasting behaviour of the ischaemic and the normal wall 
is responsible for the occurrence of left ventricular 
asynchrony and the prolongation of relaxation.' 'I 22 Parallel 
with systolic dysfunction, there were changes in the passive 
elastic properties of the ischaemic wall, with increased 
regional stiffness. This has been reported previously.' " 
The increase in regional stiffness is probably due to several 
mechanisms such as systolic overstretch of the ischaemic 
myocardium,' delayed relaxation with prolonged tension 
T 
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Figure 5 Control (CW; circles) and ischaemic (IW; squares) wall 
thickness at a common preload of 10 mm H g  at rest (B) ,  ajter 
2 h ojischaemia ( I2 ) ,  and after 4 h o j  reperfusion (R,) in the control 
(white symbols) and the nisoldipine group (niso: black symbols). 
Values are means, bars=SEM. lschaemic wull thickness in the 
control group decreased during ischaemia and reperfusion when 
compared to the control wall but remained unchanged after 
nisoldipine treatment. 
*p<O.05 v B. 
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decay during diastolic filling,j I4 and/or diastolic calcium 
overload caused by impaired calcium sequestration of the 
sarcoplasmic reticulum.” ’’ ” 
Regional lejt ventricular fiinction qf the postischaemic 
myocardium 
Postischaemic left ventricular function was characterised by 
persisting systolic bulging of the ischaemic wall four hours 
after reperfusion (table 11), whereas function of the control 
wall returned to the baseline level at the end of reperfusion. 
Some recovery of regional left ventricular systolic function 
of the ischaemic wall was possible during dopamine 
infusion, suggesting that myocardial stunning had 
occurred.’ ” However, systolic function of the postischaemic 
myocardium was not normalised during inotropic 
stimulation, indicating that there was some irreversible 
damage to the myocardium. 
Diastolic dysfunction was characterised by prolongation 
of relaxation and increased regional wall stiffness. Asynergy 
prolongs the time constant of left ventricular relaxation. 
However, regional relaxation rates cannot be measured 
accurately with the currently available techniques in the 
intact heart. Thus the time constant of relaxation is a global 
parameter which is also dependent on loading conditions.18 
With inotropic stimulation relaxation became normal, 
suggesting either an augmentation of global relaxation rates 
such as is shown to occur with the use of catecholamines,” 
or the occurrence of reversible asynchrony of the left 
ventricle, probably due to the recovery of function of the 
ischaemic wall. Inotropic stimulation may augment 
relaxation by reducing asynchrony despite persistent 
ischaemia.” In the control group, regional wall stiffness of 
the ischaemic myocardium was increased during ischaemia 
and reperfusion (fig 4). Thus regional differences in passive 
elastic properties occur during acute myocardial ischaemia of 
the left ventricle despite ventricular unloading by the assist 
device. 
Effect of nisoldipine on left ventricular function 
The effect of calcium antagonists on the ischaemic and 
postischaemic myocardium has been extensively studied in 
the An improvement in systolic dysfunction has 
been reported after pretreatment with nifedipine,” 
verapamil,j3 and other calcium channel In the 
present study little improvement in systolic function of the 
postischaemic myocardium was found after the 
administration of nisoldipine. However, regional diastolic 
wall stiffness at a common preload of 10 mm Hg was less 
during ischaemia and reperfusion (fig 4), and diastolic 
thinning of the ischaemic wall was prevented by nisoldipine, 
suggesting that this calcium antagonist has a protective effect 
on the passive elastic properties of the ischaemic 
myocardium. This effect cannot solely be explained by a 
blockade of the slow calcium channels,” and there are 
probably several mechanisms involved: 
- Calcium antagonists delay the depletion of high energy 
phosphates during ischaemia by reducing myocardial 
contractility and protecting mitochondria1 oxidative 
phosphorylation.” 
- Pretreatment with verapamil has been shown to preserve 
sarcolemmal sodium-potassium-ATPase activity and to 
augment the removal of intracellular sodium which 
accumulates during ischaemia.‘” 
- Calcium antagonists reduce the influx of sodium by direct 
blockade of the sodium channel and thus attenuate sodium 
overload of the ischaemic myocyte.4’ 
- Coronary collateral perfusion can be improved by calcium 
antagonists and thus reduce the extent of ischaemia.32 
- Blockade of the slow calcium channels reduces 
intracellular calcium concentration during prolonged 
ischaemic states and thus reduces diastolic calcium overload 
of the postischaemic 
Clinical irnplications 
There are numerous clinical situations in which the 
myocardium is subjected to transient ischaemia, including 
unstable angina, acute myocardial infarction with 
reperfusion, open heart surgery with cardioplegic arrest, or 
cardiac transplantation. Recent observations suggest that 
these situations may be associated with myocardial stunning 
after short term ischaemia. In patients with long term 
ischaemia the myocardium might be variably damaged or 
may remain reversibly depressed for prolonged periods of 
time or even chronically (hibernating myocardium). The 
evidence found in the present study indicates that diastolic 
dysfunction can be effectively attenuated by phar- 
macological manipulations such as calcium antagonists. 
Several pathogenic mechanisms, for example preservation of 
high energy phosphates, preserved sarcolemmal sodium- 
potassium-ATPase, and attenuation of sodium and/or 
calcium overload, might be interfering with the mechanism 
of cell injury. Thus calcium antagonists might prevent rather 
than simply temporarily correct postischaemic diastolic 
dysfuntion. 
Liniitations of the study 
Mechanical circulatory support was performed in the present 
study to prevent postischaemic hypotension (systolic 
pressure <50 mm Hg) which occurred in five of 10 animals. 
Without circulatory support half the animals would have 
been lost due to left ventricular dysfunction caused by the 
large ischaemic zone. On the other side, mechanical 
circulatory support certainly reduced the ischaemic damage 
by unloading the myocardium at risk and improving 
collateral perfusion. I I 
Coronary collateral perfusion was not directly measured 
except antegrade flow in the proximal circumflex artery. This 
flow does not necessarily reflect the total amount of 
collateral perfusion to the ischaemic myocardium. 
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